Vincent Guinn, MD
Clinical Cardiac Electrophysiology · Columbus, OHNPI 1528009016
Payments from drug & device makers
Across 336 payments — averaging $20.62 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novartis$2K
- Medtronic$1K
- Sanofi-aventis U.S. LLC$493
- Merck$453
- Boston Scientific$401
- Boehringer Ingelheim$383
- plus $3K from 31 others
What the payments were for
- Travel & lodging$3165%
- Food & beverage$6,51194%
- Education$1001%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novartis | 117 | $1,520 |
| Medtronic(2 entities) | 20 | $1,048 |
| Sanofi-aventis U.S. LLC | 26 | $493 |
| Merck | 28 | $453 |
| Boston Scientific | 15 | $401 |
| Boehringer Ingelheim | 18 | $383 |
| Merz North America, Inc. | 5 | $346 |
| Amarin Pharma, Inc. | 15 | $272 |
| Astellas Pharma US Inc | 9 | $233 |
| Pfizer | 7 | $184 |
| Johnson & Johnson | 11 | $173 |
| Alnylam Pharmaceuticals Inc. | 7 | $155 |
| Kowa Pharmaceuticals America, Inc. | 8 | $145 |
| Scpharmaceuticals Inc. | 1 | $133 |
| Actelion Pharmaceuticals US, Inc. | 7 | $128 |
| Angiodynamics, Inc. | 1 | $115 |
| Abbott | 5 | $114 |
| AstraZeneca | 7 | $95 |
| Bayer | 4 | $72 |
| Impulse Dynamics (USA) Inc. | 3 | $58 |
| Gilead | 4 | $56 |
| AbbVie | 2 | $40 |
| Lexicon Pharmaceuticals, Inc. | 2 | $32 |
| Cardiva Medical, Inc. | 1 | $31 |
| Abiomed | 1 | $31 |
| Inspire Medical Systems, Inc. | 1 | $25 |
| Cvrx, Inc. | 1 | $22 |
| Akcea Therapeutics, Inc. | 1 | $21 |
| Biotronik Inc. | 1 | $21 |
| Novo Nordisk | 1 | $20 |
| E.r. Squibb & Sons, L.L.C. | 1 | $19 |
| Nevro Corp. | 1 | $18 |
| Altathera Pharmaceuticals LLC | 1 | $16 |
| Edwards Lifesciences | 1 | $14 |
| Baxter Healthcare | 1 | $14 |
| Irhythm Technologies, Inc. | 1 | $14 |
| Solta Medical, A Division Of Bausch Health US, LLC | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- LINQ II$148
- FUROSCIX$133
- Reveal LINQ$125
- JARDIANCE$116
- Auryon Laser System 100-120 Vac$115
- VYNDAMAX$101
- EMBLEM$100
How this compares
$6,927 in reported general payments places this provider in the 20th percentile of 159 clinical cardiac electrophysiology providers in Ohio.
See all clinical cardiac electrophysiology providers in Ohio →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EntrestoSacubitril/Valsartan | 245 | $270,665 |
| MultaqDronedarone Hcl | 23 | $31,579 |
| Valsartan | 324 | $9,944 |
| Labetalol Hcl | 256 | $9,179 |
| SotalolSotalol Hcl | 440 | $9,061 |
| Nebivolol Hcl | 111 | $7,999 |
| Propafenone Hcl | 73 | $5,910 |
| Losartan Potassium | 495 | $5,079 |
| Amlodipine Besylate | 1,163 | $4,886 |
| Carvedilol | 414 | $3,729 |
| Warfarin Sodium | 602 | $3,347 |
| Nifedipine ErNifedipine | 85 | $3,140 |
| Lisinopril | 328 | $2,303 |
| Amiodarone Hcl | 78 | $2,217 |
| Metoprolol Succinate | 153 | $2,167 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| NovartisEntresto | $1,520 | $270,665245 claims |
| Sanofi-aventis U.S. LLCMultaq | $493 | $31,57923 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 20th percentile of 159 clinical cardiac electrophysiology providers in Ohio.
Other clinical cardiac electrophysiology in Columbus
- Anish AminColumbus$2.8M
- John HummelColumbus$1.4M
- Auroa BadinColumbus$580K
- Ralph AugostiniColumbus$552K
- Sreedhar BillakantyColumbus$458K
- Mahmoud HoumsseColumbus$319K
- Salvatore SavonaColumbus$249K
- Eugene FuColumbus$214K
- Jaret TylerColumbus$185K
- Francis HackettColumbus$153K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.